Vitasora Health Statistics
Total Valuation
Vitasora Health has a market cap or net worth of AUD 44.61 million. The enterprise value is 41.54 million.
| Market Cap | 44.61M |
| Enterprise Value | 41.54M |
Important Dates
The last earnings date was Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Vitasora Health has 1.94 billion shares outstanding. The number of shares has increased by 41.69% in one year.
| Current Share Class | 1.94B |
| Shares Outstanding | 1.94B |
| Shares Change (YoY) | +41.69% |
| Shares Change (QoQ) | +10.22% |
| Owned by Insiders (%) | 6.07% |
| Owned by Institutions (%) | 9.09% |
| Float | 1.58B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 8.90 |
| PB Ratio | 2.62 |
| P/TBV Ratio | 8.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.58 |
| EV / Sales | 8.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.00.
| Current Ratio | 2.95 |
| Quick Ratio | 1.53 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -106.25% and return on invested capital (ROIC) is -65.41%.
| Return on Equity (ROE) | -106.25% |
| Return on Assets (ROA) | -53.62% |
| Return on Invested Capital (ROIC) | -65.41% |
| Return on Capital Employed (ROCE) | -67.83% |
| Weighted Average Cost of Capital (WACC) | 1.84% |
| Revenue Per Employee | 167,019 |
| Profits Per Employee | -386,469 |
| Employee Count | 30 |
| Asset Turnover | 0.37 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Vitasora Health has paid 1,236 in taxes.
| Income Tax | 1,236 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -42.50% in the last 52 weeks. The beta is -0.44, so Vitasora Health's price volatility has been lower than the market average.
| Beta (5Y) | -0.44 |
| 52-Week Price Change | -42.50% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.03 |
| Relative Strength Index (RSI) | 49.57 |
| Average Volume (20 Days) | 737,617 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Vitasora Health had revenue of AUD 5.01 million and -11.59 million in losses. Loss per share was -0.01.
| Revenue | 5.01M |
| Gross Profit | 5.21M |
| Operating Income | -11.59M |
| Pretax Income | -11.59M |
| Net Income | -11.59M |
| EBITDA | -11.53M |
| EBIT | -11.59M |
| Loss Per Share | -0.01 |
Balance Sheet
The company has 3.10 million in cash and 26,509 in debt, giving a net cash position of 3.07 million or 0.00 per share.
| Cash & Cash Equivalents | 3.10M |
| Total Debt | 26,509 |
| Net Cash | 3.07M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 17.01M |
| Book Value Per Share | 0.01 |
| Working Capital | 5.55M |
Cash Flow
| Operating Cash Flow | -10.79M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 103.94%, with operating and profit margins of -231.37% and -231.39%.
| Gross Margin | 103.94% |
| Operating Margin | -231.37% |
| Pretax Margin | -231.37% |
| Profit Margin | -231.39% |
| EBITDA Margin | -230.20% |
| EBIT Margin | -231.37% |
| FCF Margin | n/a |
Dividends & Yields
Vitasora Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.69% |
| Shareholder Yield | -41.69% |
| Earnings Yield | -25.99% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 31, 2012. It was a reverse split with a ratio of 0.05.
| Last Split Date | Jul 31, 2012 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
Vitasora Health has an Altman Z-Score of -0.08 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.08 |
| Piotroski F-Score | 4 |